APA (7th ed.) Citation

GK, S., & SW, I. (2022). Radiotherapy-Associated Pelvic Insufficiency Fracture Treated by Romosozumab: Course of CT Attenuations at L1 and L5. Journal of the Endocrine Society, 6(12), bvac152. https://doi.org/10.1210/jendso/bvac152

Chicago Style (17th ed.) Citation

GK, Schneider, and Ing SW. "Radiotherapy-Associated Pelvic Insufficiency Fracture Treated by Romosozumab: Course of CT Attenuations at L1 and L5." Journal of the Endocrine Society 6, no. 12 (2022): bvac152. https://doi.org/10.1210/jendso/bvac152.

MLA (9th ed.) Citation

GK, Schneider, and Ing SW. "Radiotherapy-Associated Pelvic Insufficiency Fracture Treated by Romosozumab: Course of CT Attenuations at L1 and L5." Journal of the Endocrine Society, vol. 6, no. 12, 2022, p. bvac152, https://doi.org/10.1210/jendso/bvac152.